AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2011
Aug 4, 2011
29864_dirs_2011-08-04_78a3d056-d616-46c3-9ad7-b0d616b0fccd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2011-08-03
Reporting Person: BOGER JOSHUA S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-03 | Common Stock | M | 4000 | $24.66 | Acquired | 731395 | Direct |
| 2011-08-03 | Common Stock | S | 1000 | $47.26 | Disposed | 730395 | Direct |
| 2011-08-03 | Common Stock | S | 2900 | $47.91 | Disposed | 727495 | Direct |
| 2011-08-03 | Common Stock | S | 100 | $48.79 | Disposed | 727395 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-08-03 | Stock Option | $24.66 | M | 4000 | Disposed | 2011-12-10 | Common Stock (4000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 13286 | Indirect |
Footnotes
F1: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
F2: Open market sales reported on this line occurred at a weighted average price of $47.26 (range $46.59 to $47.52).
F3: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4: Open market sales reported on this line occurred at a weighted average price of $47.91 (range $47.63 to $48.58).
F5: Fully vested.